This website uses cookies. Cookies are important for the correct functioning of a website. Some of these cookies are technically essential to ensure the functionality of the website. In addition, we use some cookies to help us improve this website and your experience. If you click on "I agree", both the technically necessary cookies and the cookies for information on user behaviour are stored. However, if you click on "refuse", we only save the technically necessary cookies. Further information can be found on our data protection page.







Prof. Dr.
Franz Hessel


of Healthcare Management, Study Programme Director Healthcare Management

Room H.808

Telephone: +49 30 374 374-710

Send an email


  • Healthcare Management
  • Public Health Management
  • Evaluation in Healthcare
  • Quality Management
  • Statistics
  • Health Psychology
  • Leadership
  • Service Management
  • Scientific Writing

Office Hours: By appointment

Research Fokus

  • Health Economic Evaluation
  • Medical Decision Making Modelling
  • Health Technology Assessment
  • Market Access
  • Reimbursement Dossiers

Academic Career

Since 2011: SRH Hochschule Berlin, Professor of Healthcare Management

1997 - 1999: Postgraduate studies "Public Health and Epidemiology". Degree: Master Public Health, Ludwig-Maximilians-Universität Munich

1996: Doctorate as Dr. med. at Ludwig-Maximilians-University Munich. Topic: „Genexpresson of growth factors in human unstimulated mononuclear cells and the impact of omega3-fatty acids” at the faculty of medical sciences

1988 - 1994: Medicine, Ludwig-Maximilians-University Munich Master Public Health, Ludwig-Maximilians-University Munich

Professional Experience


2010 - 2011: Director International Health Economics Outcomes Research, Abbott Diagnostics, Wiesbaden/Chicago

2006 - 2010: Head Health Econmimcs Outcomes Research (HEOR), Sanofi-Aventis, Berlin

2004 - 2006: Alfried Krupp von Bohlen und Halbach Institute for Medical Management, University Duisburg-Essen, Senior Researcher, Head of Working Group Health Economic Evaluation, HTA and Health Services Research

2000 - 2003: Ernst-Moritz-Arndt University Greifswald, Institute for Healthcare Management, Faculty of Law and Management, Scientific Assistant, Head of Working Group Health Economic Evaluation

1995 - 1999: Clinic for Internal Medicine Ludwig-Maximilians-University München, Junior Physician, Scientific Researcher

Selected Publications

Hessel F: Arzneimittelversorgung. In: Wasem/Matusiewicz/Neumann/Noweski (Hrg.): Medizinmanagement. 2. Auflage, 2019 MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin. S. 272-297

Hessel F: The Relevance of the Analytic Validity of Genetic Biomarker Tests in Personalised Medicine in Oncology. In: Vollmann, Schildmann (ed): Personalised Medicine, Ashgate Publishing 2015

Hessel F (2015) HTA in personalized medicine technologies. In: Seitz H, Schumacher S (edt.) Biomarker Validation – Technological, Clinical and Commercial Aspects. Wiley VCH

Schermuly, C. C., Draheim, M., Glasberg, R., Stantchev, V., Tamm, G., Hartmann, M., & Hessel, F. Human resource crises in German hospitals - an explorative study Human Resources for Health, 13(1), 40, 2015

Hessel F, Pfeiffer-Gerschel T, Reimer J (2014) Die Qualität in der Versorgung Opiatabhängiger in substitutionsgestützter Behandlung – Eine Diskussion vor dem Hintergrund der PREMOS-Studie. Suchttherapie 15(02): 84-90

Glasberg, R. Hartmann, M. Draheim, M. Tamm, G. Hessel, F (2014) Risks and Crises for Healthcare Providers : The Impact of Cloud Computing. The Scientific World Journal, 2014, Article ID 524659, doi:10.1155/2014/524659

Hessel F, Freckmann G, Resch A (2013). Konsequenzen der Genauigkeit von Blutglucosemesssystemen - Klinische und ökonomische Aspekte. Der Diabetologe; e-pub ahead of print: DOI 10.1007/s11428-013-1124-1

Hessel F, Bramlage P, Wasem J, Mitzner S (2010) Cost effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol. 22; 213-220

Moock J, Hessel F, Dingler D, Kubiak T, Kohlmann T (2010) Development and Validation of the Insulin Treatment Experience Questionnaire (ITEQ). The Patient: Patient-Centered Outcomes Research 3; 45-58

Freemantle N, Hessel F (2009): The applicability and generalisability of findings from clinical trials for health policy decisions. PharmacoEconomics 27; 5-10

Berger K, Hessel F, Kreuzer J, Smala A, Diener HC (2008): Clopidogrel versus Aspirin in Patients with Atherothrombosis - CAPRIE-based Calculation of Cost-Effectiveness for Germany. Current Medical Research and Opinion, 24; 267-274

Janka HU, Hessel F, Walzer S, Müller E (2007): Improved glycemic control through treatment with insulin glargine reduces long-term complications in type 2 diabetics - a simulation with the Diabetes Mellitus Model (DMM). Int. J. of Clin. Pharm. and Therapeutics, 45; 623-630

Hessel F (2006): Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver. Cost Effectiveness and Resource Allocation, 4:16

Grill E, Hessel F, Siebert U, Schnell-Inderst P, Kunze S, Nikisch A, Wasem J (2005) Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis. BMC Public Health 2005, 5:12

Hessel FP, Wegner C, Müller J, Glaveris C, Wasem J (2003): Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy European Journal of Health Economics 5, 58-63

Hessel FP, Mitzner S R, Rief J, Guellstorff B, Steiner S, Wasem J (2003): Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver International 23 (Suppl 3) 66-72


Since 2017: External Examiner City University of London

2011 - 2012: Method Advisory Board Diagnostic Assessment Programme of the National Institute for Healthc and Clinical Excellence (NICE)

2009 - 2014: Board of the German Society for Health Economics (DGGÖ)

Since 2014: Member of the Drug Commission of the German Medical Association (AkdÄ)